These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4580000)

  • 1. [Production of fluorescence labeled "anti-cholera" test sera and their testing on model studies].
    Oberdoerster F; Markuse I; Patzwaldt HG; Winkler D; Zlotowicz C
    Z Gesamte Hyg; 1973 Mar; 19(3):225-8. PubMed ID: 4580000
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocyte response to a purified bacterial toxin (choleragen) and toxoid: cytokinetics, immunoglobulin class, and specificity.
    Kateley JR; Lyons SF; Friedman H
    J Immunol; 1974 Apr; 112(4):1452-60. PubMed ID: 4592602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunofluorescent and agglutination reaction of Vibrio fetus].
    Bingöl R; Blobel H
    Zentralbl Bakteriol Orig; 1970; 215(3):316-9. PubMed ID: 4923789
    [No Abstract]   [Full Text] [Related]  

  • 5. Vibriocidal test and its parameters.
    Ganguly R; Deb BC; Shrivastava DL
    Indian J Med Res; 1969 May; 57(5):815-22. PubMed ID: 5820430
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemistry of vibrio cholerae virulence. II. Skin permeability factor-cholera enterotoxin production in a chemically defined medium.
    Callahan LT; Ryder RC; Richardson SH
    Infect Immun; 1971 Nov; 4(5):611-8. PubMed ID: 5170548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and durability of antibody responses in Atlantic cod (Gadus morhua L.) immunised with Vibrio anguillarum O2b.
    Lund V; Børdal S; Schrøder MB
    Fish Shellfish Immunol; 2007 Oct; 23(4):906-10. PubMed ID: 17604648
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental cholera in infant mice: protective effects of antibody.
    Chaicumpa W; Rowley D
    J Infect Dis; 1972 May; 125(5):480-5. PubMed ID: 5023642
    [No Abstract]   [Full Text] [Related]  

  • 10. A serological survey for cholera antibodies in the population of Jerusalem and surroundings.
    Gerichter CB; Sechter I; Cohen J; Davies AM
    Isr J Med Sci; 1973 Aug; 9(8):980-5. PubMed ID: 4753851
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative studies on the protective value of different antigenic preparations from cholera vibrios.
    Sanyal SC; Narayanaswami A; Mukerjee S
    Indian J Med Res; 1969 Sep; 57(9):1621-8. PubMed ID: 5369787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Avidity of specific antibodies in the sera of cholera patients and vibrio carriers].
    Bunin KV; Firsanov VI; Parfenova NN; Kravtsov EG; Nechaeva IP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):70-4. PubMed ID: 1015080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of cholera toxin in vivo.
    Peterson JW; LoSpalluto JJ; Finkelstein RA
    J Infect Dis; 1972 Dec; 126(6):617-28. PubMed ID: 4577423
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro potency tests for anti-hog cholera antibodies: a test for anti-hog cholera serums and a test for herd exposure.
    Phillips CE
    Am J Vet Res; 1968 May; 29(5):1097-102. PubMed ID: 4868986
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection afforded by anti-hemolysin against V. cholerae El Tor infection in experimental cholera.
    Chaicumpa W; Samrejrongroj P; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):294-301. PubMed ID: 7434081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of vibriocidal antibodies using agar plague techniques.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(5):708-14. PubMed ID: 5001359
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative assay of a protein antigen of vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    Aust J Exp Biol Med Sci; 1971 Dec; 49(6):605-12. PubMed ID: 5170447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of exotoxins and endotoxins of cholera-like vibrions using the immunoelectrophoretic method and gel precipitation reaction].
    Vvedenskaia OI; Givental' NI; Ermol'eva ZV
    Antibiotiki; 1972 Jul; 17(7):602-7. PubMed ID: 4655010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differences in certain immunological indices among persons who have had cholera and among Vibrio carriers].
    Bunin KV; Nechaeva IP; Flerova NK; Kravtsov EG; Venknevich BK
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):29-32. PubMed ID: 1199587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.